Table 2.
Bone mineral density assessments performed and results for entire cohort by gender
| All (n = 92a) | Women (n = 44a) | Men (n = 48a) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | Baseline | 1 year | 2 years | Baseline | 1 year | 2 years | Baseline | 1 year | 2 years |
| BMD studies performed | 92 | 66 | 48 | 44 | 31 | 22 | 48 | 35 | 26 |
| Anti-fracture therapy in prior year | - | 4 (6.1) | 10 (20.8) | - | 3 (9.7) | 6 (27.3) | - | 1 (2.9) | 4 (15.4) |
| Glucocorticoid in prior year | - | 3 (4.5) | 5 (10.4) | - | 2 (6.5) | 5 (22.7) | - | 1 (2.9) | 0 (0) |
| BMD measurement | |||||||||
| Femur T-score | - 0.8 (±1.5) | -1.0 (±1.4) | - 1.1 (±1.3) | - 1.2 (±1.4) | - 1.3 (±1.2) | - 1.4 (±0.9) | - 0.5 (±1.4) | - 0.7 (±1.5) | - 1.0 (±1.6) |
| Femur absolute (g/cm3) | 0.956 (±0.197) | 0.940 (±0.193) | 0.923 (±0.178) | 0.876 (±0.176) | 0.872 (±0.161) | 0.871 (±0.126) | 1.028 (±0.187) | 0.999 (±0.202) | 0.964 (±0.203) |
| AP spine T-score | - 0.2 (±1.9) | - 0.2 (±1.9) | - 0.1 (±1.9) | - 0.7 (±1.8) | - 0.6 (±1.6) | - 0.5 (±1.2) | 0.3 (±1.8) | 0.2 (±2.0) | 0.3 (±2.2) |
| AP spine absolute (g/cm3) | 1.207 (±0.242) | 1.205 (±0.241) | 1.211 (±0.231) | 1.135 (±0.250) | 1.142 (±0.223) | 1.151 (±0.173) | 1.273 (±0.217) | 1.260 (±0.246) | 1.262 (±0.264) |
Data are shown as mean (±standard deviation) or number (%)
Abbreviations: BMD bone mineral density, AP anterioposterior
aAt baseline femur BMD not measured in three participants (one woman, two men). At 1 year femur BMD not measured in two participants (one woman, one man), at 2 years femur BMD not measured in one participant (one woman)